Atropine Sulfate Injection, Solution
Product Images NDC 0404-9989

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 0404-9989). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of atropine sulfate, shown as a molecular diagram with labeled functional groups and stereochemistry. The structure includes a bicyclic tropane ring system attached to an ester and aromatic phenyl ring, with associated sulfate and water molecules.*

FDA Label Image

Image1.jpg (Image1)

Table presenting recommended adult dosage for Atropine Sulfate injection, including use cases: antisialagogue or other antivalgal, organophosphorus or muscarinic mushroom poisoning, and bradysystolic cardiac arrest, with corresponding dose ranges and repeat intervals.*

FDA Label Image

Image2.jpg (Image2)

A data table titled 'How Supplied' listing atropine sulfate injection solution concentrations, package sizes, and corresponding NDC numbers. It shows two concentrations: 0.4 mg/mL and 1 mg/mL, with package sizes of 1 vial, 10 vials, and 25 vials under each concentration, paired with different NDC codes.*

FDA Label Image

Label1.jpg (Label1)

Atropine Sulfate 1 mg/mL injection, USP, single-dose vial label. The label indicates intravenous use, sterile product, and storage instructions. Packaged by Henry Schein, Inc., with an NDC of 0404-9989-01. The label includes lot, expiration placeholders, manufacturer information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.